Lymph node stromal and vascular proliferations Read more about Lymph node stromal and vascular proliferations
Autoimmune and medication-induced lymphadenopathies Read more about Autoimmune and medication-induced lymphadenopathies
Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancer Read more about Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancer
Use of CD42b immunohistochemical stain for the detection of Histoplasma Read more about Use of CD42b immunohistochemical stain for the detection of Histoplasma
Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer Read more about Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer
Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification Read more about Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies Read more about A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies
Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues Read more about Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues
Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases Read more about Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL Read more about Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL